Musashi-1 Is a Novel Immunohistochemical Marker of Neuroendocrine Carcinoma of the Lung
Small cell lung cancer (SCLC) and large cell neuroendocrine carcinoma (LCNEC) have recently been grouped as lung neuroendocrine carcinomas (NECs). Because these lung NECs are clinically malignant and their treatment strategies differ from those of non-SCLC, the quality of diagnosis has a significant...
Main Authors: | Yu Izaki, Vishwa Jeet Amatya, Takahiro Kambara, Kei Kushitani, Yoshihiro Miyata, Morihito Okada, Yukio Takeshima |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-11-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/15/23/5631 |
Similar Items
-
Impact of Musashi-1 and Musashi-2 Double Knockdown on Notch Signaling and the Pathogenesis of Endometriosis
by: Theresa Strauß, et al.
Published: (2022-03-01) -
Equivalent Survival between Gastric Large-Cell Neuroendocrine Carcinoma and Gastric Small-Cell Neuroendocrine Carcinoma
by: Zefeng Li, et al.
Published: (2023-09-01) -
Small Molecule Palmatine Targeting Musashi-2 in Colorectal Cancer
by: Xue Zhang, et al.
Published: (2022-01-01) -
Imaging of Neuroendocrine Prostatic Carcinoma
by: Ahmed Taher, et al.
Published: (2021-11-01) -
Metastatic lung neuroendocrine carcinoma presenting as a breast lump
by: Tai-Chien Huang, et al.
Published: (2019-01-01)